| Product Code: ETC9389409 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Pharmacogenetic Testing Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 South Africa Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 South Africa Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Africa Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growing prevalence of chronic diseases in South Africa |
4.2.3 Government initiatives and investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for genetic testing services |
4.3.3 Lack of skilled healthcare professionals for interpreting genetic test results |
5 South Africa Pharmacogenetic Testing Market Trends |
6 South Africa Pharmacogenetic Testing Market, By Types |
6.1 South Africa Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 South Africa Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 South Africa Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 South Africa Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 South Africa Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 South Africa Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 South Africa Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 South Africa Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 South Africa Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 South Africa Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 South Africa Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 South Africa Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 South Africa Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 South Africa Pharmacogenetic Testing Market Export to Major Countries |
7.2 South Africa Pharmacogenetic Testing Market Imports from Major Countries |
8 South Africa Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing among healthcare providers |
8.2 Number of research studies and publications related to pharmacogenetic testing in South Africa |
8.3 Percentage of healthcare facilities offering pharmacogenetic testing services |
9 South Africa Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 South Africa Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Africa Pharmacogenetic Testing Market - Competitive Landscape |
10.1 South Africa Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 South Africa Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here